Thromboangiitis Obliterans Treatment
Although there is not cure for Buerger's disease, the most important therapy is avoiding exposure to tobacco. This includes exposure to cigarette smoke. The smoking cessation program must not include nicotine replacement, because nicotine is the substance that worsens symptoms. Additional therapy involves protecting the hands and feet form exposure to cold and injury. Controversial therapy involves surgical sympathectomy. This procedure destroys the nerves that constrict the blood vessels in the hands and feet.
Treatment for Buerger's disease may include:
Thromboangiitis Obliterans Questions For Doctor
The following are some important questions to ask before and after the treatment of Buerger's disease.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Do I need to lose weight?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- Do I need a special exercise program?
- Will I need physical therapy?
- Will I need occupational therapy?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Thromboangiitis Obliterans Specialist
Continue to Thromboangiitis Obliterans Home Care
- Abi-Saleh B, Chirculescu C, Eggleston KL, Takubo T Jr, Byrd RP Jr, Roy TM. Buerger's disease and pulmonary hypertension: a rare association? Tenn Med. 2005 Jan;98(1):37-8, 42. 
- Bozkurt AK, Besirli K, Koksal C, Sirin G, Yuceyar L, Tuzun H, Sayin AG. Surgical treatment of Buerger's disease. Vascular. 2004 May-Jun;12(3):192-7. 
- Cooper LT, Tse TS, Mikhail MA, et al. Long-term survival and amputation risk in thromboangiitis obliterans (Buerger's disease). J Am Coll Cardiol. 2004 Dec 21;44(12):2410-1. 
- Naito AT, Minamino T, Tateno K, Nagai T, Komuro I. Steroid-responsive thromboangiitis obliterans. Lancet. 2004 Sep 18-24;364(9439):1098.